Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets

The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.

WuXi AppTec plans to build a new site in Singapore

Better serving global partners and advancing healthcare innovation

Brii Bio inks partnership with China Resources Pharmaceutical to advance the commercialization of Long-acting COVID-19 neutralizing antibody therapy

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals

Healthcare Triangle closes $6.5 million private placement

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

W.R. Grace to expand capacity at small-molecule API plant

The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction

Eversana partners with Compai Pharma to expand commercialisation services across APAC

EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners

Healthcare Triangle announces $6.5 million private placement

Evonik launches non-animal-derived collagen platform for medical device applications

Fermentation-based manufacturing leverages Evonik’s biotechnology platform

Biosynth Carbosynth expands peptide offering with acquisition of Pepscan

Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.